Company number 09470532
Status Active
Incorporation Date 4 March 2015
Company Type Private Limited Company
Address 20-22 BEDFORD ROW, LONDON, UNITED KINGDOM, WC1R 4JS
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc
Since the company registration ten events have happened. The last three records are Total exemption full accounts made up to 31 December 2016; Confirmation statement made on 4 March 2017 with updates; Appointment of Mr Larry Dillaha as a director on 1 February 2017. The most likely internet sites of RENABLE PHARMA LTD are www.renablepharma.co.uk, and www.renable-pharma.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and eleven months. The distance to to Battersea Park Rail Station is 3.3 miles; to Brondesbury Park Rail Station is 4.3 miles; to Barnes Bridge Rail Station is 6.8 miles; to Beckenham Hill Rail Station is 7.9 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Renable Pharma Ltd is a Private Limited Company.
The company registration number is 09470532. Renable Pharma Ltd has been working since 04 March 2015.
The present status of the company is Active. The registered address of Renable Pharma Ltd is 20 22 Bedford Row London United Kingdom Wc1r 4js. . JORDAN COMPANY SECRETARIES LIMITED is a Secretary of the company. ANDERSON, Katherine is a Director of the company. DILLAHA, Larry is a Director of the company. Director PODOLSKI, Joseph has been resigned. The company operates in "Research and experimental development on biotechnology".
renable pharma Key Finiance
LIABILITIES
n/a
CASH
n/a
TOTAL ASSETS
n/a
All Financial Figures
Current Directors
Secretary
JORDAN COMPANY SECRETARIES LIMITED
Appointed Date: 04 March 2015
Resigned Directors
Director
PODOLSKI, Joseph
Resigned: 01 February 2017
Appointed Date: 04 March 2015
78 years old
Persons With Significant Control
Repros Therapeutics Inc.
Notified on: 6 April 2016
Nature of control: Ownership of shares – 75% or more
RENABLE PHARMA LTD Events
22 Mar 2017
Total exemption full accounts made up to 31 December 2016
10 Mar 2017
Confirmation statement made on 4 March 2017 with updates
07 Mar 2017
Appointment of Mr Larry Dillaha as a director on 1 February 2017
06 Mar 2017
Termination of appointment of Joseph Podolski as a director on 1 February 2017
11 Jul 2016
Total exemption small company accounts made up to 31 December 2015
...
... and 0 more events
08 Mar 2016
Annual return made up to 4 March 2016 with full list of shareholders
Statement of capital on 2016-03-08
14 Apr 2015
Current accounting period shortened from 31 March 2016 to 31 December 2015
05 Mar 2015
Director's details changed for Joseph Podolski on 4 March 2015
05 Mar 2015
Director's details changed for Katherine Anderson on 4 March 2015
04 Mar 2015
Incorporation
-
MODEL ARTICLES ‐
Model articles adopted (Amended Provisions)
Statement of capital on 2015-03-04